JP5015376B2 - プロテオグリカンを減少させた軟組織異種移植片 - Google Patents

プロテオグリカンを減少させた軟組織異種移植片 Download PDF

Info

Publication number
JP5015376B2
JP5015376B2 JP2000598085A JP2000598085A JP5015376B2 JP 5015376 B2 JP5015376 B2 JP 5015376B2 JP 2000598085 A JP2000598085 A JP 2000598085A JP 2000598085 A JP2000598085 A JP 2000598085A JP 5015376 B2 JP5015376 B2 JP 5015376B2
Authority
JP
Japan
Prior art keywords
xenograft
article
manufacture
tissue
soft tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000598085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002536109A5 (cg-RX-API-DMAC7.html
JP2002536109A (ja
Inventor
アール.ストーン ケビン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aperion Biologics Inc
Original Assignee
Aperion Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aperion Biologics Inc filed Critical Aperion Biologics Inc
Publication of JP2002536109A publication Critical patent/JP2002536109A/ja
Publication of JP2002536109A5 publication Critical patent/JP2002536109A5/ja
Application granted granted Critical
Publication of JP5015376B2 publication Critical patent/JP5015376B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
JP2000598085A 1999-02-11 2000-02-08 プロテオグリカンを減少させた軟組織異種移植片 Expired - Fee Related JP5015376B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/248,336 US6267786B1 (en) 1999-02-11 1999-02-11 Proteoglycan-reduced soft tissue xenografts
US09/248,336 1999-02-11
PCT/US2000/003233 WO2000047131A1 (en) 1999-02-11 2000-02-08 Proteoglycan-reduced soft tissue xenografts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012095033A Division JP5654516B2 (ja) 1999-02-11 2012-04-18 プロテオグリカンを減少させた軟組織異種移植片

Publications (3)

Publication Number Publication Date
JP2002536109A JP2002536109A (ja) 2002-10-29
JP2002536109A5 JP2002536109A5 (cg-RX-API-DMAC7.html) 2011-06-23
JP5015376B2 true JP5015376B2 (ja) 2012-08-29

Family

ID=22938672

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000598085A Expired - Fee Related JP5015376B2 (ja) 1999-02-11 2000-02-08 プロテオグリカンを減少させた軟組織異種移植片
JP2012095033A Expired - Lifetime JP5654516B2 (ja) 1999-02-11 2012-04-18 プロテオグリカンを減少させた軟組織異種移植片

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012095033A Expired - Lifetime JP5654516B2 (ja) 1999-02-11 2012-04-18 プロテオグリカンを減少させた軟組織異種移植片

Country Status (6)

Country Link
US (2) US6267786B1 (cg-RX-API-DMAC7.html)
EP (1) EP1158930A1 (cg-RX-API-DMAC7.html)
JP (2) JP5015376B2 (cg-RX-API-DMAC7.html)
AU (1) AU760424B2 (cg-RX-API-DMAC7.html)
CA (1) CA2361579A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000047131A1 (cg-RX-API-DMAC7.html)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039678A1 (en) * 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
US6972041B1 (en) * 1998-03-16 2005-12-06 Crosscart, Inc. Bone xenografts
US6383732B1 (en) * 1999-02-11 2002-05-07 Crosscart, Inc. Method of preparing xenograft heart valves
WO1999051170A1 (en) * 1998-04-02 1999-10-14 Crosscart, Inc. Bone xenografts
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6267786B1 (en) * 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
US20030068815A1 (en) * 1999-02-11 2003-04-10 Stone Kevin R. Sterilized xenograft tissue
US6471723B1 (en) * 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
JP2004529711A (ja) * 2001-05-07 2004-09-30 クロスカート インコーポレイテッド 粘膜下異種移植片
CA2455827C (en) * 2001-08-13 2015-06-09 University Of Florida Research Foundation, Inc. Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7264966B2 (en) * 2002-01-23 2007-09-04 Olympus Optical Co., Ltd. Method of isolating cell or sample to be analyzed in cell
WO2003105737A1 (en) * 2002-06-14 2003-12-24 Crosscart, Inc. Galactosidase-treated prosthetic devices
US7008763B2 (en) * 2002-09-23 2006-03-07 Cheung David T Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US8043854B2 (en) 2003-05-15 2011-10-25 Waseda University Method of decellularizing tissues
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
JP2007529278A (ja) 2004-03-17 2007-10-25 レビビコア, インコーポレイテッド 機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP2502494A3 (en) 2005-10-31 2012-12-19 Velico Medical, Inc. Novel alpha-galactosidases
EP2502491B1 (en) 2005-10-31 2017-05-10 Velico Medical, Inc. Novel alpha-galactosidases
US20070299517A1 (en) * 2006-06-21 2007-12-27 Howmedica Osteonics Corp. Articular cartilage implant
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
US8192491B2 (en) 2006-10-09 2012-06-05 Active Implants Corporation Meniscus prosthetic device
EP2076218B1 (en) 2006-10-09 2016-03-09 Active Implants Corporation Meniscus prosthetic device
US8007992B2 (en) 2006-10-27 2011-08-30 Edwards Lifesciences Corporation Method of treating glutaraldehyde-fixed pericardial tissue with a non-aqueous mixture of glycerol and a C1-C3 alcohol
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20080255665A1 (en) * 2007-04-11 2008-10-16 Active Implants Corporation Anchored prosthetic meniscus device
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US8162961B2 (en) * 2007-07-23 2012-04-24 Zimmer Orthobiologies, Inc. Medical devices and methods for cutting and suturing biological tissue
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US20090181807A1 (en) * 2008-01-16 2009-07-16 Jason Miguel De Los Santos Golfing aid
KR100947553B1 (ko) * 2008-02-14 2010-03-12 주식회사 바이오랜드 생체조직 이식재 및 그의 제조 방법
US20090286289A1 (en) * 2008-03-10 2009-11-19 Pang Danny Z Production of Hyaluronate Unsaturated Disaccharides and its Application
US8361147B2 (en) 2008-04-09 2013-01-29 Active Implants Corporation Meniscus prosthetic devices with anti-migration features
US8016884B2 (en) 2008-04-09 2011-09-13 Active Implants Corporation Tensioned meniscus prosthetic devices and associated methods
US7611653B1 (en) 2008-04-09 2009-11-03 Active Implants Corporation Manufacturing and material processing for prosthetic devices
US7991599B2 (en) 2008-04-09 2011-08-02 Active Implants Corporation Meniscus prosthetic device selection and implantation methods
WO2010099463A2 (en) * 2009-02-27 2010-09-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Joint bioscaffolds
BR122014006876B1 (pt) 2010-03-23 2020-09-29 Edwards Lifesciences Corporation Método para preparar material de membrana de tecido bioprotético
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8920498B2 (en) 2010-05-06 2014-12-30 Stichting Katholieke Universiteit Non-resorbable meniscus prosthesis for the human knee joint
CN102946916B (zh) 2010-06-17 2015-03-18 爱德华兹生命科学公司 通过化学修饰抗原性碳水化合物稳定生物假体组织的方法
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
DE102011008604A1 (de) 2011-01-14 2012-07-19 Tutogen Medical Gmbh Herstellung eines Transplantats aus tierischer Dermis mit Natriumsulfidlösung
US9540610B2 (en) 2011-04-28 2017-01-10 Warsaw Orthopedic, Inc. Collagen and cell implant
KR102109309B1 (ko) 2011-04-28 2020-05-12 라이프셀 코포레이션 조직 생성물의 효소처리방법
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
CN105561391A (zh) 2012-05-11 2016-05-11 Rti外科手术有限公司 异种移植软组织植入物及制造和使用的方法
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
ES2846758T3 (es) * 2013-11-04 2021-07-29 Lifecell Corp Métodos para eliminar la alfa-galactosa
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10940184B2 (en) 2017-01-30 2021-03-09 Lifecell Corporation Tissue matrix materials and enzymatic adhesives
CN111544652A (zh) 2017-01-30 2020-08-18 生命细胞公司 转谷氨酰胺酶处理的产品
CN110678590B (zh) 2017-05-31 2022-07-19 爱德华兹生命科学公司 胶原纤维和由其形成的制品
AU2019212059A1 (en) 2018-01-23 2020-05-21 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
CN113164258B (zh) 2018-11-01 2024-08-27 爱德华兹生命科学公司 经导管再生肺动脉瓣
CA3143206A1 (en) 2019-12-09 2021-06-17 Edwards Lifesciences Corporation Bioprosthetic tissue preparation
KR102559788B1 (ko) * 2022-04-21 2023-07-27 주식회사 티앤알바이오팹 다단계 탈세포화된 조직 매트릭스 및 이의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55122544A (en) * 1979-03-15 1980-09-20 Seikagaku Kogyo Co Ltd Preparation of bone for transplantation
WO1997012035A2 (en) * 1995-09-27 1997-04-03 Nextran Inc. Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
WO1998007837A1 (en) * 1996-08-23 1998-02-26 The Austin Research Institute Improved nucleic acids for reducing carbohydrate epitopes
US5782915A (en) * 1995-09-15 1998-07-21 Stone; Kevin R. Articular cartilage heterografts

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1045752A (en) 1975-05-26 1979-01-09 Robert W. Jackson Prosthetic implant
US4344193A (en) 1980-11-28 1982-08-17 Kenny Charles H Meniscus prosthesis
US4400833A (en) 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4502161A (en) 1981-09-21 1985-03-05 Wall W H Prosthetic meniscus for the repair of joints
SE446372B (sv) 1983-02-03 1986-09-08 Medinvent Sa Blodkerlsprotes for anvendning som shunt mellan blodkerl
IL68218A (en) 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4609627A (en) 1983-08-01 1986-09-02 New York Blood Center, Inc. Enzymatic conversion of certain sub-type A and AB erythrocytes
US4932973A (en) 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
US4789663A (en) 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
US4597266A (en) 1985-05-28 1986-07-01 Cryolife, Inc. Freezing agent and container
US4627853A (en) 1985-05-29 1986-12-09 American Hospital Supply Corporation Method of producing prostheses for replacement of articular cartilage and prostheses so produced
US4678470A (en) 1985-05-29 1987-07-07 American Hospital Supply Corporation Bone-grafting material
US4755593A (en) 1985-07-24 1988-07-05 Lauren Mark D Novel biomaterial of cross-linked peritoneal tissue
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
GB8618374D0 (en) 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US4846835A (en) 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US4880429A (en) 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US5306311A (en) 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5158574A (en) 1987-07-20 1992-10-27 Regen Corporation Prosthetic meniscus
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US5007934A (en) * 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
US5116374A (en) 1989-03-02 1992-05-26 Regen Corporation Prosthetic meniscus
US5078744A (en) 1987-09-04 1992-01-07 Bio-Products, Inc. Method of using tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
US5171273A (en) 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
US5067962A (en) 1989-04-18 1991-11-26 Baxter International Inc. Bioprosthetic ligament
US5171660A (en) 1989-04-26 1992-12-15 Cryolife, Inc. Process of revitalizing cells and tissue prior to cryopreservation
US5521087A (en) 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5171322A (en) 1990-02-13 1992-12-15 Kenny Charles H Stabilized meniscus prosthesis
US5092894A (en) 1990-02-13 1992-03-03 Kenny Charles H Stabilized meniscus prosthesis
EP0483944B1 (en) 1990-10-31 1995-07-05 El Gendler Flexible membranes produced from organic bone matrix for skeletal repair and reconstruction
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5160313A (en) 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US5216126A (en) 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US5507810A (en) 1991-10-07 1996-04-16 Osteotech, Inc. Processing of fibrous connective tissue
US5333626A (en) 1991-12-31 1994-08-02 Cryolife, Inc. Preparation of bone for transplantation
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US5352463A (en) * 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
FR2699408B1 (fr) * 1992-12-21 1995-03-24 Bioland Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
US5358525A (en) 1992-12-28 1994-10-25 Fox John E Bearing surface for prosthesis and replacement of meniscal cartilage
ATE265191T1 (de) 1994-03-14 2004-05-15 Cryolife Inc Herstellungsverfahren von gewebe zur implantation
WO1995026740A1 (en) 1994-03-31 1995-10-12 Diacrin, Inc. Improved methods for transplantation using modified cells and t cell inhibitory agents
EP0755402B1 (en) 1994-04-13 2008-05-14 Biotransplant, Inc Alpha(1,3) galactosyltransferase negative swine
WO1995033828A1 (en) 1994-06-03 1995-12-14 Diacrin, Inc. Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants
US5516532A (en) 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5904716A (en) 1995-04-26 1999-05-18 Gendler; El Method for reconstituting cartilage tissue using demineralized bone and product thereof
US5913900A (en) * 1995-06-07 1999-06-22 Corsscart, Inc. Substantially native meniscal cartilage heterografts
US5865849A (en) * 1995-06-07 1999-02-02 Crosscart, Inc. Meniscal heterografts
US6049025A (en) * 1995-09-15 2000-04-11 Stone; Kevin R. Articular cartilage xenografts
US6110206A (en) * 1995-09-15 2000-08-29 Crosscart, Inc. Anterior cruciate ligament xenografts
US6267786B1 (en) * 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55122544A (en) * 1979-03-15 1980-09-20 Seikagaku Kogyo Co Ltd Preparation of bone for transplantation
US5782915A (en) * 1995-09-15 1998-07-21 Stone; Kevin R. Articular cartilage heterografts
WO1997012035A2 (en) * 1995-09-27 1997-04-03 Nextran Inc. Transgenic animals for xenotransplantation with reduced antibody-mediated rejection
WO1998007837A1 (en) * 1996-08-23 1998-02-26 The Austin Research Institute Improved nucleic acids for reducing carbohydrate epitopes

Also Published As

Publication number Publication date
EP1158930A1 (en) 2001-12-05
WO2000047131A1 (en) 2000-08-17
US6267786B1 (en) 2001-07-31
AU2985700A (en) 2000-08-29
CA2361579A1 (en) 2000-08-17
JP5654516B2 (ja) 2015-01-14
US20010039459A1 (en) 2001-11-08
US6455309B2 (en) 2002-09-24
JP2012166039A (ja) 2012-09-06
AU760424B2 (en) 2003-05-15
JP2002536109A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
JP5654516B2 (ja) プロテオグリカンを減少させた軟組織異種移植片
JP5015377B2 (ja) アルデヒド及びグリコシダーゼ処理した軟組織及び骨組織異種移植片
US6758865B1 (en) Soft tissue xenografts
US6046379A (en) Meniscal xenografts
US5984858A (en) Meniscal xenografts
US5944755A (en) Articular cartilage xenografts
US6049025A (en) Articular cartilage xenografts
US6093204A (en) Meniscal heterografts
US6110206A (en) Anterior cruciate ligament xenografts
JP6728307B2 (ja) 組織製品の酵素処理方法
US5782915A (en) Articular cartilage heterografts
JP4535324B2 (ja) 殺菌された異種移植片組織
US5913900A (en) Substantially native meniscal cartilage heterografts
US5902338A (en) Anterior cruciate ligament heterograft
WO2001091671A1 (en) Xenograft heart valves
JP2004529711A (ja) 粘膜下異種移植片
US6210440B1 (en) Anterior cruciate ligament xenografts

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100518

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20100518

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100518

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100607

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100623

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110419

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110419

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111018

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120117

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120418

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120522

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120607

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150615

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5015376

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees